Regulation of HPV Replication.
Regulation of HPV Replication.
批准号:
10347959
负责人:
Laimonis A. LAIMINS
金额:
$24.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-24 至 2023-08-31
关键词:
ATR geneAffectAtaxia TelangiectasiaBiological AssayCell Cycle ProgressionCell Cycle RegulationCell ProliferationCellsCleaved cellComplexDNADNA DamageDNA Double Strand BreakDNA RepairDNA Repair PathwayDNA biosynthesisDNA replication forkDNA-Directed DNA PolymeraseDNA-Directed RNA PolymeraseDNA-protein crosslinkEnzymesEpisomeExposure toFailureG2 PhaseGenetic TranscriptionGenomeHigher Order Chromatin StructureHuman PapillomavirusHybridsInvestigationLeadLentivirusLife Cycle StagesLigationLinkMaintenanceMeasuresNuclearPathway interactionsPlayProcessProductionProliferatingProteinsRNARegulationResolutionRoleRotationSingle-Stranded DNAStratified EpitheliumStratified Squamous EpitheliumStratum BasaleStressTOP1 geneTOP2A geneTimeTopoisomeraseTopoisomerase IITorsionType I DNA TopoisomerasesVertebral columnViralViral GenomeViral ProteinsVirionVirus Replicationcell growthhigh riskinsightknock-downmemberphosphodiesterpreventrepairedsmall hairpin RNAviral DNA
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
Human papillomaviruses (HPV) infect stratified squamous epithelia and link their productive life cycles to the
differentiation of the host cell. HPVs infect cells in the basal layer of stratified epithelia and establish genomes
as low copy nuclear episomes. When HPV infected cells migrate from the basal layer, they re-enter S/G2 phases
in the most differentiated layers to allow for vegetative viral DNA replication in a process referred to as
amplification. HPV replication is regulated by viral proteins as well as cellular factors that control cell cycle
progression, differentiation and DNA damage repair pathways. Our recent studies have shown that activation of
both the ataxia telangiectasia (ATM) pathway as well as the ataxia telangiectasia and Rad3-related (ATR)
pathway is necessary for differentiation-dependent amplification of viral genomes and we have identified many
members of these pathways that provide important functions. Our studies further indicate that enhanced levels
of DNA breaks in HPV positive cells are responsible for activation of these pathways but the mechanism behind
this increase has not been identified. DNA breaks can be induced by exposure to exogenous DNA damaging
agents or through endogenous pathways such as through the action of topoisomerases. We have recently
demonstrated that the type II topoisomerase TOP2is responsible for generating over 50% of DNA breaks in
HPV positive cells. Topoisomerases regulate higher order chromatin structures through the transient breaking
and re-ligation of one or both strands of the phosphodiester backbone of duplex DNA. Our studies have shown
that the levels of TOP2 are increased by a 3 to 5-fold in cells with high-risk HPV genomes. Importantly,
knockdown of TOP2 blocks HPV genome replication and moderately reduces viral transcription but has no
effect on cell proliferation. Furthermore, knockdown of TOP2reduced the amount of DNA breaks in HPV
positive cells which results in decreased DDR nuclear repair foci. While our assays demonstrated that over half
of total DNA breaks in HPV positive cells were induced by TOP2 other factors must be responsible for the
remaining breaks. Strong candidates for this activity are two other topoisomerases, TOP2and TOP1, and
investigation of this possibility as well as an examination of the role of these enzymes in viral replication is the
focus of this R21 application. These studies will provide important insights into how the differentiation-dependent
HPV life cycle is regulated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of HPV Replication.
-
批准号:10495235
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2021
-
负责人:Laimonis A. LAIMINS
-
依托单位:
Role of CTCF in HPV replication and viral DNA looping
-
批准号:9094415
-
项目类别:
-
资助金额:$22.4万
-
财政年份:2015
-
负责人:Laimonis A. LAIMINS
-
依托单位:
2nd ASM Conference on Manipulation of Nuclear Processes by DNA Viruses
-
批准号:8204189
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2011
-
负责人:Laimonis A. LAIMINS
-
依托单位:
HPV and the DNA Damage Response
-
批准号:8097390
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2010
-
负责人:Laimonis A. LAIMINS
-
依托单位:
Renewal: HPV and the DNA Damage Response
-
批准号:10439190
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2010
-
负责人:Laimonis A. LAIMINS
-
依托单位:
HPV and the DNA Damage Response
-
批准号:8677767
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2010
-
负责人:Laimonis A. LAIMINS
-
依托单位:
Renewal: HPV and the DNA Damage Response
-
批准号:10612428
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2010
-
负责人:Laimonis A. LAIMINS
-
依托单位:
HPV and the DNA Damage Response
-
批准号:7988344
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2010
-
负责人:Laimonis A. LAIMINS
-
依托单位:
HPV and the DNA Damage Response
-
批准号:8270643
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2010
-
负责人:Laimonis A. LAIMINS
-
依托单位:
HPV and the DNA Damage Response
-
批准号:8518050
-
项目类别:
-
资助金额:$28.85万
-
财政年份:2010
-
负责人:Laimonis A. LAIMINS
-
依托单位:
Life Cycle of Human Papillomaviruses
-
批准号:7916073
-
项目类别:
-
资助金额:$27.15万
-
财政年份:2009
-
负责人:Laimonis A. LAIMINS
-
依托单位:
Role of E7 in HPV Infections
-
批准号:7962280
-
项目类别:
-
资助金额:$24.33万
-
财政年份:2008
-
负责人:Laimonis A. LAIMINS
-
依托单位:
Role of E7 in HPV Infections
-
批准号:6842445
-
项目类别:
-
资助金额:$20.99万
-
财政年份:2004
-
负责人:Laimonis A. LAIMINS
-
依托单位:
Training Program in Viral Replication
-
批准号:8485507
-
项目类别:
-
资助金额:$15.28万
-
财政年份:2004
-
负责人:Laimonis A. LAIMINS
-
依托单位:
Training Program in Viral Replication
-
批准号:7074756
-
项目类别:
-
资助金额:$14.53万
-
财政年份:2004
-
负责人:Laimonis A. LAIMINS
-
依托单位:
Training Program in Viral Replication
-
批准号:6944961
-
项目类别:
-
资助金额:$14.53万
-
财政年份:2004
-
负责人:Laimonis A. LAIMINS
-
依托单位:
Training Program in Viral Replication
-
批准号:7235327
-
项目类别:
-
资助金额:$14.53万
-
财政年份:2004
-
负责人:Laimonis A. LAIMINS
-
依托单位:
Training Program in Viral Replication
-
批准号:7423941
-
项目类别:
-
资助金额:$14.53万
-
财政年份:2004
-
负责人:Laimonis A. LAIMINS
-
依托单位:
Training Program in Viral Replication
-
批准号:6800898
-
项目类别:
-
资助金额:$7.26万
-
财政年份:2004
-
负责人:Laimonis A. LAIMINS
-
依托单位:
MECHANISMS OF HUMAN PAPILLOMAVIRUS INFECTION
-
批准号:6660462
-
项目类别:
-
资助金额:$18.05万
-
财政年份:2002
-
负责人:Laimonis A. LAIMINS
-
依托单位:
海外基金